The Trump administration Friday introduced Operation Warp Speed, a $10 billion public-private partnership intended to accelerate development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics by January 2021.

The White House said the federal government will oversee treatment trial protocols, lead the selection of manufacturing partners and work on a distribution plan that includes necessary materials, such as vials and appropriate storage.

As a condition of receiving support from Operation Warp Speed, companies will provide donated allocations of countermeasures developed, including an eventual vaccine.

Related News Articles

Headline
“The COVID-19 pandemic has proved that crisis tends to be a driver of innovation,” writes Jonathan Bandel, vice president of strategy and innovation for New…
Headline
The Food and Drug Administration Wednesday updated its guidance on enforcement policy for non-invasive remote monitoring devices that support patient…
Headline
Over 10,000 eligible nursing homes, or 76% of the field, will receive a portion of $333 million in COVID-19 Provider Relief Funds for meeting infection control…
Headline
The departments of Health and Human Services and Defense have agreed to purchase the first 300,000 doses of the investigational antibody drug bamlanivimab,…
Headline
The Centers for Medicare & Medicaid Services yesterday announced an interim final rule establishing additional Medicare hospital payment to support…
#HealthCareInnovation Thursday Blog
When the first case of coronavirus was confirmed in New Rochelle, New York, in early March, White Plains Hospital, a 292-bed tertiary care hospital located…